We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
RANDOX LABORATORIES

CANON

Canon U.S.A., Inc. provides digital imaging solutions for the healthcare sector, including digital detectors, digital... read more Featured Products: More products

Download Mobile App





Canon Medical Developing Rapid Genetic Testing System for Novel Coronavirus

By LabMedica International staff writers
Posted on 08 Apr 2020
Print article
Illustration
Illustration
Canon Medical Systems Corporation (Ohtawara, Japan) has commenced the development of a rapid genetic testing system for the novel coronavirus (COVID-19). The project is part of a research program focusing on the development of diagnostic methods for COVID-19 led by the Japan Agency for Medical Research and Development (AMED).

Canon Medical offers a full range of diagnostic medical imaging solutions including CT, X-Ray, Ultrasound, Vascular and MR, as well as a full suite of Healthcare IT solutions, across the globe. The company was selected to participate in the research program in cooperation with Nagasaki University. The test and the reagents developed for COVID-19 RNA testing is based on the LAMP method4) developed by Eiken Chemical Co., Ltd. (Tokyo, Japan) and are used with a compact isothermal amplified gene fluorescent detector manufactured by Canon Medical to detect the presence of virus. In comparison to the conventional test method of real-time PCR, the LAMP method allows for detection of the virus to be performed more easily and quickly, which makes it suitable for testing in local areas where infection is prevalent.

Related Links:
Canon Medical Systems Corporation
Eiken Chemical Co., Ltd.



Print article

Channels

Molecular Diagnostics

view channel
Image: Histopathology of neurofibrillary tangles in the brain of a patient with Alzheimer`s disease (Bielschowski silver stain) (Photo courtesy of Dimitri P. Agamanolis, MD).

Alzheimer's Disease Subtypes Proposed from Brain Gene Expression Profiles

Alzheimer’s disease (AD) is the most common form of dementia in the elderly, estimated to affect more than 5.8 million individuals in the USA and more than 50 million worldwide, with almost half of individuals... Read more

Industry

view channel
Illustration

Thermo Fisher Acquires Point-of-Care Molecular Diagnostics Provider Mesa Biotech

Thermo Fisher Scientific Inc. (Waltham, MA, USA) has entered into a definitive agreement to acquire Mesa Biotech (San Diego, CA, USA), a privately held molecular diagnostic company, for approximately USD... Read more
Copyright © 2000-2021 Globetech Media. All rights reserved.